XIAODI SU, Ph.D.

Xiaodi Su, Ph.D., is a Senior Investment Manager with Lilly Asia Ventures (LAV). Prior to joining LAV, Xiaodi was a Life Science Specialist at L.E.K., where she led and supported more than 15 projects focusing on pharmaceutical and medtech sectors. Xiaodi holds a Ph.D. in immunology and microbial pathogenesis from the Weill Cornell Graduate School of Medical Sciences and B.S. in biology from Fudan University.